Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Cromafiban stands head and shoulders above others in its class

Nov. 10, 1999

Soluble CD39: novel antiplatelet agent enters the pipeline at Immunex

Nov. 9, 1999

Angiomax available through expanded access study in HIT/HITTS patients

Nov. 3, 1999

3-D's new protease (thrombin) inhibitors

Nov. 2, 1999

Corvas begins second phase II trial for anticoagulant rNAPc2

Nov. 2, 1999

RWJ-56110: design, synthesis and characterization of new peptidomimetic PAR-1 antagonist

Oct. 29, 1999

Anticoagulants remain focus of research at Warner-Lambert

Oct. 29, 1999

Warner-Lambert discloses another series of anticoagulants

Oct. 28, 1999

Warner-Lambert patents new anticoagulants with quinolinone structure

Oct. 27, 1999

First approval obtained for bivalirudin

Oct. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...